We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MDRNA, Inc. Demonstrates the Potential for Greater Efficacy in Cancer with an UsiRNA Combination Approach

News   Mar 19, 2010

 
MDRNA, Inc. Demonstrates the Potential for Greater Efficacy in Cancer with an UsiRNA Combination Approach
 
 
 

RELATED ARTICLES

A New Formulation Helps the Medicine Go Down

News

Scientists have developed a novel pharmaceutical formulation to administer triclabendazole - an anti-parasitic drug used to treat a type of flatworm infection - in billions of tiny capsules.

READ MORE

50% of Trial Subjects Who Took a Placebo Reported Suffering an Adverse Event

News

New research published in Trials explores the negative effects that can be caused by participants being administered placebos in clinical trials, finding that half of people taking placebos reported side effects from the trial intervention.

READ MORE

The Source of Stem Cells Points to Two Proteins

News

Negative feedback between HIPPO and Par complex components ensure robust lineage segregation in mice.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE